Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Enalapril maleate
Kent Pharma (UK) Ltd
C09AA02
Enalapril maleate
5mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02050501
Patient Information Leaflet ENALAPRIL MALEATE TABLETS 2.5 MG ENALAPRIL MALEATE TABLETS 5 MG ENALAPRIL MALEATE TABLETS 10 MG ENALAPRIL MALEATE TABLETS 20 MG READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have further questions, please ask your doctor or your pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What ENALAPRIL MALEATE TABLETS are and what they are used for 2. What you need to know before you take ENALAPRIL MALEATE TABLETS 3. How to take ENALAPRIL MALEATE TABLETS 4. Possible side effects 5. How to store ENALAPRIL MALEATE TABLETS 6. Contents of the pack and other information 1. WHAT ENALAPRIL MALEATE TABLETS ARE AND WHAT THEY ARE USED FOR ENALAPRIL MALEATE TABLETS (referred to as ‘ENALAPRIL’ throughout this leaflet) contains the active substance enalapril maleate. ‘ENALAPRIL’ belongs to a group of medicines known as ACE inhibitors (Angiotensin Converting Enzyme Inhibitors). ‘ENALAPRIL’ works by causing your blood vessels to widen. This helps your blood pressure to fall. It also makes it easier for your heart to pump blood around your body. The medicine usually starts to work within an hour, and the effect lasts for at least 24 hours. Some people will require several weeks of treatment until the best effect on their blood pressure is seen. ‘ENALAPRIL’ IS USED: • To treat high blood pressure – also called hypertension • To treat heart failure (weakening of heart function). It can lower the need to go to hospital and can help some patients live longer. • To prevent the signs of heart failure. The signs include: shortness of breath, tiredness after light ph Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Enalapril 5mg Tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg enalapril (as maleate). Also contains 79.7 mg of lactose per tablet, for a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet. White circular biplanar uncoated tablets with 5 embossed on one face and score line on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of hypertension: All grades of essential hypertension and renovascular hypertension. Treatment of heart failure: In heart failure, Enalapril 5 mg, tablets should be used as an adjunctive therapy with non-potassium-sparing diuretics and, where appropriate, digitalis. Enalapril 5 mg, tablets have been shown to improve symptoms, retard the progression of the disease, and reduce mortality and hospitalisation. Prevention of symptomatic heart failure: When used in asymptomatic patients with left ventricular dysfunction, Enalapril 5 mg, tablets retard the development of symptomatic heart failure, and reduce hospitalisation for heart failure. Prevention of coronary ischaemic events in patients with left ventricular dysfunction: Enalapril 5 mg, tablets reduce both the incidence of myocardial infarction and hospitalisation for unstable angina pectoris. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The absorption of enalapril is not affected by food intake. The dose should be individualised according to the patient profile (see section 4.4) and blood pressure response. Hypertension: The initial dose is 5 to maximally 20 mg, depending on the degree of hypertension and the condition of the patient (see below). Enalapril is given once daily. In mild hypertension, the recommended dose is 5 to 10 mg. Patients with a strongly activated renin-angiotensin-aldosterone system (e.g., renovascular hypertension, salt and/or volume depletion, cardiac decompensation, or severe hypertension) may experience an excessive blood pressure fall following the initial dose. A starting do Read the complete document